Supplementary Figure 5 from Erlotinib Prolongs Survival in Pancreatic Cancer by Blocking Gemcitabine-Induced MAPK Signals

Koji Miyabayashi,Hideaki Ijichi,Dai Mohri,Motohisa Tada,Keisuke Yamamoto,Yoshinari Asaoka,Tsuneo Ikenoue,Keisuke Tateishi,Yousuke Nakai,Hiroyuki Isayama,Yasuyuki Morishita,Masao Omata,Harold L. Moses,Kazuhiko Koike

crossref（2023）

引用 0|浏览4

暂无评分

摘要

Supplementary Figure 5 PDF file - 1755K, Gemcitabine-induced EGFR/ErbB2-MAPK signal activation was a common phenomenon in PDAC and lung cancer cells irrespective of KRAS mutation status and gemcitabine sensitivity.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要